Achieving Quality in Cardiovascular Imaging
Pamela S. Douglas(Duke University), John A. Spertus(Spertus Institute for Jewish Learning and Leadership), Robert L. McNamara, Linda D. Gillam, Eric D. Peterson(Duke University), James G. Jollis(Durham University), Frederick A. Masoudi, Harlan M. Krumholz(Robert Wood Johnson Foundation), Ami E. Iskandrian(AstraZeneca (United Kingdom)), Jersey Chen, Emile R. Mohler(Korea Advanced Institute of Science and Technology), Robert C. Hendel, Manesh R. Patel(Clinical Research Institute)
Cited by 129
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Mayo Clinic Proceedings
|Mayo Clinic Proceedings|2000|2.2k